18 July
2024
Creightons
Plc
Audited Preliminary
results
Annual General
Meeting
Creightons Plc (the "Group" or
"Creightons") brand owners and manufacturers of personal care,
beauty, and fragrance products, is pleased to announce its
preliminary results for the year ended 31 March 2024.
The Company's annual report and
financial statements for the year ended 31 March 2024 will be made
available from the Company's website at: https://www.creightonsplc.com
In addition, the document will be
uploaded to the National Storage Mechanism and will be available
for viewing at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The Company's Annual General
Meeting will take place at the offices of
Potter & Moore Innovations Ltd, 1210 Lincoln Road,
Peterborough, PE4 6ND on 28 August 2024 at 12:00 noon.
We are pleased to announce an
in-person presentation for analysts and investors scheduled for
Wednesday 24th July at 11:00 AM. If you wish to attend,
please email us at creightons@piworld.co.uk
for further instructions and details.
We look forward to your
participation.
Financial highlights
· Improved gross margin performance on lower revenue of
£53.2m (2023: £58.6m) a reduction of
9.2%, as a result of cost reduction and
product portfolio rationalisation.
· Gross
profit margin increased by 1.3% to 42.9% from 41.6%.
· Full
year operating profit margin (before exceptional items) of 2.9%
(2023: 2.7%).
· EBITDA
for the year was £3.2m (2023: £3.0m).
· Exceptional items included Emma Hardie brand intangible asset
impairment of £4.4m (2023:£Nil).
· Adjusted diluted earnings per share excluding exceptional
items, was positive 1.42p (2023:1.05p).
· Stock
held on hand reduced by £2.0m to £8.2m (2023: £10.2m).
· Net
cash on hand (cash and cash equivalents less short-term element of
obligations under finance leases and borrowings) is positive £2.2m
(2023: negative £1.2m).
· The
Directors propose a final dividend of 0.45 pence per ordinary share
for the year ended 31 March 2024 (2023:
Nil).
Operational highlights
· Private label saw growth in revenue whilst Branded and
Contracts sales saw a downturn in revenue activity:
o Sales of retailer own label products increased by 7.9% to
£23.7m.
o Overall branded sales have decreased by 7.6% to
£21.0m.
o Contract manufacturing sales decreased by 38.9% to
£8.4m.
o The
Group's total overseas business decreased by 20.1% to £8.5m (2023:
£10.6m).
· The
Group has continued to successfully implement the six-point plan.
The remedial measures were intended to restore profitability,
reduce costs and inventory and to return to positive cash flow. The
resulting actions and their impact are summarised in the following
six areas:
o Increase in selling prices to our customers
§ Sales teams continued the process of Cost Price Increase
(C.P.I) monitoring across all categories of supply. This was used
as the basis to negotiate sales price increases with customers.
This has proved successful as indicated by the improvement in gross
margin.
o Reduction in overheads
§ Cost rationalisation has seen Administrative costs decrease by
5.6% to £17.8m (2023: £18.9m).
o Increase efficiency and capacity in each factory so as to
maximise the benefit of single shift working
§ Manufacturing team reducing to one shift at both Peterborough
(September 2022) and Devon (September 2023).
o Relocating the customer facing side of the business,
warehousing, picking and packing and logistics back to the
Peterborough site
§ Restructuring warehousing and logistics has seen Distribution
costs decrease by 10.6% to £3.5m (2023: £3.9m).
o Reduction in stock levels, targeting £2m reduction against
prior year
§ We
have achieved stock reductions of £2.0m to the end of March 2024,
achieving a closing stock balance of £8.2m (2023: £10.2m) without
any reduction in effective service levels to customers.
o New
and non-critical capital expenditure cancelled unless payback less
than 9 months
§ Purchase of property, plant and equipment has reduced to £0.3m
(2023: £0.8m).
The combined effect of these
measures, carried out over the course of the year and in particular
the second half of the year, has been to improve profitability and
generate positive cashflow.
Enquiries - Analysts and
Investors:
Philippa Clark, Director, Creightons
Plc
info@creightons.com
01733 281058
Roland Cornish / Felicity Geidt,
Beaumont Cornish Limited
0207 628 3396
Chairman's statement
I take pleasure in presenting my
first statement following my appointment as Chair of the Board on 7
March 2024. The structure of this report will be different to
previous years with a top-level overview of the Group's performance
in the past year, changes to the board and senior management team
and an overview of the direction of the business over the next few
years.
Our new Managing Director, Philippa
Clark will provide a more detailed review of the performance
including a review of revenue and brand performance. This will be
followed by a report on the Group's financial results.
Overview of performance
In common with many UK
manufacturing businesses, we have been operating during a period of
significant inflationary pressures, challenging supply chains and
weakening consumer demand. The objective remains to meet our
customer expectations and to deliver top line revenue growth whilst
also relentlessly focusing on the areas within our control to
recover margins following the erosion over the past two years and,
matching our overhead costs to revenue and reducing stock
levels.
Whilst results show revenue falling
to £53.2m (2023: £58.6m), EBITDA has increased to £3.2m (2023:
£3.0m) and operating profit before exceptional items has decreased
marginally to £1.54m (2023: £1.58m). The operating margin
percentage before exceptional items has improved to 2.9% in the
year ended 31 March 2024 compared to 2.7% for the year ended 31
March 2023. A significant feature of this has been a gradual
improvement throughout the year with margins significantly improved
in the second half of the year. This is covered in more detail by
Philippa Clark in her report as Managing Director.
Revenue performance across the three
revenue streams has been mixed with:
· growth
of £1.7m in the Private label revenue,
· decreased revenue through Brands of £1.7m, with some brands
unperforming and lower revenue from reducing the tail of
underperforming products and
· decreased revenue from contract manufacturing. Most of this
reduction arose from our decision to curtail sales to
businesses where credit insurance cover was removed, and the
group considered it advisable to manage credit risks. Also, two key
customers reduced orders due to declining consumer demand and
overstocks.
Gross margins have continued to
improve throughout the year and by the end of March were ahead of
those achieved before they were adversely impacted by the
inflationary pressures of the past two years. These improved
margins have been achieved through a combination of increased
selling prices, removing low margin products from sales mix,
product cost engineering and improvements in production
efficiencies. We are now seeing an easing of supplier price
pressure in most areas although not all.
Overheads have been reduced to ensure
they match the underlying activity levels of the Group.
Manufacturing operations are now on a single shift basis across
both sites. There have also been benefits arising from lower
utility costs as wholesale prices have fallen. Warehousing costs
have reduced due to the stock reduction programme and relocating
most finished goods distribution back in-house. The impact of these
changes has been to reduce the breakeven sales level on a
month-by-month basis which will enable the business to leverage
pre-tax profit growth from existing revenue and future growth.
Improved output levels in manufacturing operations are helping to
increase capacity.
One area of underperformance relates
to the Emma Hardie business which was acquired on 28 July 2021 for
a total consideration of £6.2m. The annual review of the
value-in-use of the Emma Hardie brand, which considers the ability
to generate growth in revenue and a review of the likely cash
generation from future revenue, in accordance with the requirements
of IAS 36, resulted in an exceptional impairment charge of £4.45m.
This non-cash exceptional charge, in the current year, has
materially adversely impacted the reported pre-tax profit. The
remaining associated intangible brand value of £0.66m reflects an
accounting assessment of discounted future cash flows from the Emma
Hardie brand, based upon current performance and an estimate of
future sales and costs.
This impairment will also result in a
derecognition of the goodwill value of £1.28m, relating to the
deferred tax associated with the Emma Hardie brand, with
consequential adjustments to the deferred tax accrual. The net
effect of these is a tax charge of £0.17m.
The underlying profit generation
together with the significant reduction in stock levels has
resulted in a dramatic improvement in the cash position with net
borrowings falling by £4.8m to £0.8m (2023: £5.6m). The Group chose
to repay 50% of the outstanding loan balance of the term loan used
to partly fund the acquisitions in 2021.
Building a team for the
future
Following Bernard Johnson's
departure in November 2023, the Board asked the two Executive
Directors, Philippa Clark and Martin Stevens to manage the routine
operations of the business for an interim period and complete
ongoing internal improvement programmes. In addition, they reviewed
the Emma Hardie business and integrated it within the Group's
operations, significantly reducing the overheads attributable to
the brand and further reducing staffing levels to align with
planned activity. This allowed the Board time to evaluate the
various options for the organisation of the Board and the Senior
Management Team. On completion of this review the Board announced
the following changes on 7 March 2024.
· Philippa Clark was appointed as Group Managing Director. She
will continue to be supported by Martin Stevens in his Executive
Director role as Group Deputy Managing Director.
· William McIlroy retired from his Executive roles as Chairman
and CEO and will remain on the Board as a Non-Executive
Director.
· Paul
Forster was appointed Non-Executive Chair of the Board.
· Brian Geary has joined the board as a Non-Executive
Director.
I would like to take this
opportunity to thank Bernard Johnson for his contribution to the
business, which would not be where it is today without his vision
and drive. I would also like to thank William McIlroy for his
contribution and support over his tenure in his Executive roles and
look forward to his support and guidance as I settle into my new
role.
I believe the new Board provides a
good balance of experience to support the management team as they
evolve the strategy to grow the business to meet the needs of
stakeholders.
I am pleased to report that
Philippa Clark has settled into her role and is being actively
supported by Martins Stevens and the other senior
Executives. The Executive team, under the
leadership of our new Managing Director is actively engaged in
developing plans to grow sales, protect and improve margins and
leverage our infrastructure to grow pre-tax profits and margins.
The Board recognises the importance of maintaining stability and
focus as we come out of this transitional period, and our
collective efforts are geared towards sustaining and advancing the
positive trajectory of our organisation.
Looking forward
The Group's focus will be to
pursue new growth opportunities, growing revenues organically by
using our in-depth market knowledge, product development expertise
and brand marketing skills to:
· identify new products ranges for our brands and
customers.
· extending the distribution of our brands, both within the UK
and internationally.
· increase penetration into the private label sector, where we
have range launches with two new customers in the coming
year.
· targeting contract business where customers' requirements
align with our core strengths and flexible manufacturing
capabilities.
The Group will continue to invest
in the research and development of new brands to address changing
market opportunities.
The work of the past year in
improving margins, aligning cost to match activity and throughput
levels, along with the significant spare capacity available by
introducing additional shifts, if required, places the Group in a
strong position to generate profits from additional revenue.
The Group is generating positive EBITDA and cash
flows from its core operations which underlines the ability to
generate profitable growth. There are still opportunities to
grow revenue and the sales team is being strengthened to deliver
those opportunities with a Director of Global Sales (non-statutory
Director) joining the group in May 2024.
The Group is committed to
recovering our underlying operating profits (before exceptional
items) levels, currently standing at 4.0% of revenue in the second
half of the year to March 2024, to levels enjoyed in the
past.
The Group's dynamic structure
continues to give it a competitive advantage allowing it to respond
quickly and effectively to customer requirements. It also provides
a competitive advantage with post-acquisition integration by
providing synergies not available to all market participants. The
Group will continue to look for acquisitions for brands that can
generate long term growth in revenue, profits and cash generation.
However, it will be much more focused on ensuring a good return can
be delivered on its investments.
Dividend
The Board proposes a final
dividend of 0.45 pence per ordinary share, subject to approval at
the Annual General Meeting (2023: Nil). This is in line with the
Directors' intention to reinstate paying dividends and to align
future payments with the underlying profits and positive cash flow
of the business.
Conclusion
I would like to take this
opportunity to thank every one of the Group's employees who have
continued to work together to enable us to deliver an improving
trading performance. I would also like to thank our customers,
shareholders and suppliers for their support and loyalty to the
Group.
Paul
Forster
Non-Executive Chair of the Board
16
July 2024
Managing Director's
statement
A Challenging Year
This year's results represent a
strong internally focussed strategy to ensure we tackled and
conquered the challenges bought on by the tough economic conditions
of the past two years, coupled with the ongoing macroeconomic and
geopolitical pressures. Therefore, we have ensured that the key
business fundamentals have been at the core of our activities
during the year to ensure the Group continues to deliver a
sustainable and stable business.
The difference in operating
performance between H1 and H2 of the year ended 31 March 2024
demonstrate the impact of this focus. Despite the sales downturn in
H2 against H1, gross profit margins were up by 1.5% (H1 2024:
42.2%), with full year margin of 42.9% being up 1.3% (2023: 41.6%).
Key cost reductions in administration and distribution also
provided significant gains in operating performance
overall.
|
H1
(Unaudited)
|
H2
(Unaudited)
|
Year ended 31 March
2024
|
|
£000
|
£000
|
£000
|
Revenue
|
27,555
|
25,639
|
53,194
|
Gross profit
|
11,632
|
11,198
|
22,830
|
Gross profit %
|
42.2%
|
43.7%
|
42.9%
|
Operating profit before exceptional
items
|
506
|
1,032
|
1,538
|
Operating profit before exceptional
items %
|
1.8%
|
4.0%
|
2.9%
|
Exceptional items
|
-
|
(4,466)
|
(4,466)
|
Finance Costs
|
(204)
|
(145)
|
(349)
|
EBITDA before exceptional
items
|
1,358
|
1,881
|
3,239
|
Profit / (Loss) before tax
|
302
|
(3,579)
|
(3,277)
|
Profit / (Loss) after tax
|
285
|
(3,812)
|
(3,527)
|
Key achievements have been made in
margin improvement, overhead and stock reduction, restructuring
supply chain and positive cash generation. However, the drive to
ensure a strong core business has come at the expense of sales
growth in the contract manufacturing division and a softening of
growth in our brands where a refocussing of the product portfolio
has been a priority to ensure margins are protected and enhanced
where possible.
The strategy of pursuing a
multi-channel approach to the market and a broad multi-category
product offering continues to serve us well during times when
consumer demand is impacted by a cost of living crisis.
Revenue stream
performance
Private Label
Private label sales have increased
sales by 7.9% to £23.7m (2023: £22.0m) as consumers continue to
seek performance products at value prices. Creightons continues to
be the leading supplier in the UK for private label supply achieved
through exceptional product development, quality manufacturing and
both consistency and speed of supply. This is evidenced by the fact
that the Group has achieved the number one position as a key
supplier with a major UK retailer. This is in addition to a good
solid performance across the customer base resulting in sales
growth.
This position is achieved via the
Groups' ability to develop products that deliver relevant, consumer
focussed, performance all whilst successfully managing customer
forecasts, stock and service levels into a demanding mass retailer
customer base.
Margin performance in this area has
also delivered through successfully implementing cost price
increases to customers but also taking the decision to exit
products or ranges which no longer meet our contribution margin
requirements.
Category expertise and Research and
Development are both key measures of success in this division and
these both continue to be a priority for investment.
Contract Manufacturing
Conversely, the contract sales have
experienced a downturn during the period of 38.9% to £8.4m (2023:
£13.8m). In the main this is due to masstige and premium brands
either reducing order books due to declining consumer demand and
overstocking, or are no longer covered by credit insurance and we
have chosen to exit as this is a key requirement in managing our
business risk.
Brands
Overall Brands have seen a
reduction of 7.6% to £21.0m (2023: £22.8m). This decline is due to
two key exceptional factors in the year.
1. A £1.8m loss in one
international market with Balance Active where a distributor lost
significant distribution by diversifying their business too quickly
at the expense of the Balance Active brand.
2. The internal
decision to discontinue 45% of the brand portfolio product offering
from 334 products to 184 products. This accounted for a reduction
of £1.1m sales of products that had either poor margin, low sales
volumes or a combination of both. This repositioning and focus of
the brand offer have had positive impacts on stocks, margin and
sales team focus.
Brands have performed where the
price point and offer continues to engage the consumer, resulting
in gains in both store distribution numbers and new customer
listings in a very challenging UK market specifically for Balance
Active Formula, TZone, Feather & Down, The Curl Company and the
Creightons range of branded products.
· TZone
achieved a new key grocery launch in the UK into 135 stores and
gained an additional 557 stores in an existing Grocery
listing.
· Feather & Down has an additional 341 stores with extra
distribution in the UK.
· Balance Active is already listed in a leading UK grocer but
has an additional 557 stores with the launch of new product
development (NPD) serums from June 2024. A new listing for the
brand was also secured in another major UK retailer in the period
into 102 stores.
· The
Curl Company extended into an additional 100 stores in Scandinavia
and launched for the first time into 182 stores in the
UAE.
· Creightons Frizz No More launched into a major retailer in
Spain as the Group enters the Spanish market for the first
time.
Margins are performing well through
negotiated customer price increases and product cost engineering
initiatives. This is despite a strong discontinuation programme
initiated across all brands, exiting products where margins and
volume combinations were no longer meeting expectations.
Emma Hardie
The gross sales contribution of the
brand has been flat this year at £3.2m. The autonomous, independent
approach in managing the brand for the past two years has been a
factor. In addition, entering the Chinese market has been the
dominant strategy and whilst it showed initial signs of positive
sales at the end of 2022 and the early part of 2023, this quickly
reversed during 2023. The landscape changed significantly during
the year in China proving the chosen sales model to be ineffective
and unprofitable. A decision to put activities in China on hold was
made in December 2023.
The Emma Hardie brand and its team
are now fully incorporated into the wider business. This ensures
full control of costs, sales strategy and team management. A
revised sales strategy is being executed into 2024
including:
· a full
review and potential new approach in China
· refocused efforts on digital platforms including The Hut
Group, Sephora and Amazon
· investment in EmmaHardie.com
· positioning the brand into the travel sector.
Recent launches on EasyJet inflight
in May 2024 and a 6 month trial launch into Luton Airport Duty Free
in the summer of 2024 are both being progressed.
The brand continues to perform well
in its original retail home at Marks & Spencer (M&S) in the
UK, with an increase in end consumer sales of 19% in 2023/2024
against the previous year. This demonstrates continued consumer
demand for the brand. Plans are in place during 2024/2025 with
M&S for additional investment in the brand including dual
siting in key performing stores, pop-up opportunities, in-store
events and improved positioning in the beauty hall. All with the
objective of giving more exposure to the brand and engaging more
consumers.
Digital and Social
This year has seen an increase in
our efforts with both digital and social platforms.
Feather & Down and Emma Hardie
total brand sales both have considerable contributions from digital
sales at 48% and 52% respectively of their total brand sales. This
includes Amazon Vendor UK and the pure beauty platform
players.
· A key
distribution channel for brands which have higher price points and
more limited bricks and mortar distribution.
· Two
higher price point brands, Emma Hardie and Janina, have recently
been transferred to Amazon Seller UK with initial positive results
on both sales and margin - improving from the original listings on
Amazon Vendor.
· Feather & Down and Emma Hardie launches onto Amazon
Germany and Amazon USA which have taken longer than originally
planned due to unanticipated protracted set up issues with Amazon.
It is anticipated that the growth in these new markets will be slow
and steady initially as brand awareness campaigns in these new
markets also need to be activated.
· Social
activities are live and growing across all key platforms such
as Instagram, Facebook and TikTok with a focus on Balance
Active, TZone, Feather & Down and Emma Hardie.
· TikTok
shop strategies are being implemented for select brands during
2024.
Research and Development
As we continue to develop the
business, the nature of the research and development (R&D) has
become more sophisticated, including additional time and investment
in trend monitoring, consumer research, consumer testing,
independent validation and claims substantiation.
These activities have continued
throughout the year ended 31 March 2024 to expand our portfolio of
product offering and capabilities, with key areas of focus being
the development of unique and technically challenging formulations
across Facial and Body Skincare. This requires a constant
monitoring of key trend materials to ensure that we are meeting the
consumers evolving needs and delivering new product development
quickly and efficaciously.
Looking forward, the team continue
to invest time and resource into exploring new categories and
technologies. As highlighted last year, the importance of SPF in
the skincare and suncare categories is a key growth area of the
sector. We are continuing to invest in delivering futureproofed SPF
formulations, delivering high UV protection in formats that offer
improved performance and product aesthetics. Textures have also
become key in this category requiring additional R&D
development. This work and investment will be an ongoing and
continuing piece of investment over the coming years.
A continuing and critical role of
our R&D team is responding to the challenges of increasing raw
material costs and availability. Therefore, cost mitigation through
resourcing and finding alternative materials in conjunction with
our procurement team, is a necessary activity that requires
significant lab time to validate alternatives to help avoid
excessive cost increases and maintain margins.
One of the drivers of growth in the
Private Label division is extending into new categories. As
highlighted, this would include SPF skincare and the Sun Protection
category. Other categories including non-licenced Healthcare and
Sexual Health products and new developments in skincare including
products supporting the skin's microbiome, probiotics and fermented
ingredients. Continual developments in new formats and textures are
also a key development area. This work also benefits new product
development (NPD) and development of our brands.
Manufacturing and Operations
Operationally one of the key goals
has been to reduce warehousing costs. By reducing stock and
improving the management of space this goal has been achieved. The
benefit being the considerable reduction on relying on a 3PL
solution. Maximising procurement savings and reducing overheads
have been equally important. The team continue to reduce buying
costs of both packaging and key materials and we have succeeded in
reducing our cost base to be in line with our revenue
footprint.
The key drivers in the period in
manufacturing have been centred around improving efficiencies to
realise maximum benefit from reducing to one-shift last year.
Targeted machinery investments, improved training programmes of key
production staff and working towards improving change-over times
are all contributing positively to achieving improved outputs and
efficiencies.
There is more work to be done in all
areas as we move into the coming year and the team remain
determined in ensuring gains continue to be made.
The
Future and Our Strategy
A continual review of the market,
our customers strategies, category and product opportunities
coupled with our experience and knowledge is undertaken throughout
the year in order to ensure that our key strategic objectives are
relevant and achievable. These are reviewed and monitored with the
main board and senior team to ensure consistency in approach. The
goal is to deliver a consistent, stable business that delivers
increasing value for all stakeholders.
Develop and Cultivate the Core Private Label
Business
· Retain
the dominant position in UK supply.
· Focus
on margin positive products.
· Work
with the best in class retailers.
· Ensure
Research and Development (R&D) category development drives new
sales opportunities.
Build and Develop the Groups' Brands
· Expand
UK distribution footprint - there are additional distribution gains
to be had.
· Invest
in additional resource to grow and expand international
markets.
· Ensure
Brands fill the 'white space' where possible and the propositions
are clear.
· Ensure
Brands have clear customer need states.
Expand with New Brands - Developed or
acquired
· Where
the fit is right and adds value to the Group's total Brand
portfolio.
· Where
the opportunity and positioning fill the 'white space' or
unfulfilled consumer need.
· Where
the sales and margin enhancement deliver additional business
value.
Build on Digital Platform Brand Sales
· Ongoing development of Amazon Vendor and Amazon Seller
including developing selected international markets.
· Investment into our own .com sites where the brand positioning
will succeed.
· Grow
relationships with key pure beauty players where the brand fit
makes sense.
Investment in Research and Development (R&D) and Product
Category Expertise
· Essential for growing the Private Label business by entering
new product types and related categories.
· Speed
to Market focus.
· Meeting and anticipating consumer needs - for both Brand and
Private Label divisions.
· Remain
at the cutting edge of trend, ingredients, product textures and
formats.
· Evaluation of materials with low carbon footprint for more
sustainable products.
Focus on Operational Efficiencies & Cost
Control
· Output
and capacity focussed capital investment.
· Structured training programmes throughout the operational
functions.
· Continual review of ensuring our cost footprint fits our sales
and profit profiles.
· Review
the manufacturing strategy and utilise IT to enhance our
productivity and manufacturing investments.
· Ensure
the Group's costs and asset base match demand, environmental and
safety requirements.
Meet Environmental and Sustainable Targets
· The
business has committed to SBTi validated emissions reduction
targets. Please see further detail outlined in the TCFD report per
page 24 to 32 of the full accounts.
· Scope
1 and 2 emissions will reduce by 42% and Scope 3 emissions by 25%
by 2030.
· For
FY23/24 we have seen a decrease in scope 1 and 2 emissions of
7.8%.
· We
have just completed the tenth year of holding the RSPO supply chain
accreditation.
· Now
sourcing 99.9% of our palm derivatives from RSPO sustainable
sources.
· For
FY23/24 the amount of recycled plastic in our packaging has
increased by 5.3% to 203.9 tonnes.
· We
will be completing the climate related module for CDP in
FY24/25.
Summary
Despite a challenging year the
Group's strong focused strategy on ensuring the business continues
to successfully navigate market pressures and challenges is
beginning to produce positive results. We have been determined in
our efforts in delivering operational profitability, positive cash
generation and reducing the overall cost base to be in line with
our revenue performance. The result for the second half of the year
provides evidence that we are on the right track.
The Board believes that the
restructured management team, ongoing positive customer
relationships and strong business fundamentals will enable the
Group to proactively manage new challenges and take advantage of
any new opportunities that may arise.
The Management Team remains focussed
on delivering the Group's strategic and financial aims. Immediate
priorities include increasing the awareness and distribution of our
brands, accelerating organic sales in all divisions, nurturing
customer relationships and keeping R&D central to driving the
business forward.
Finally, I would like to thank our
valued team of employees, customers, suppliers and all
stakeholders, especially those who have responded so positively
through this challenging period.
Philippa Clark
Managing Director
Financial Report
Overview of Financial performance
The Group has exhibited significant
improvements in its operating performance. Despite a reduction in
revenue year on year of 9.2% operating
profit margin before exceptional costs increased to 2.9% (2023:
2.7%). The decrease in sales activity has been due to a combination
of factors, these include, but are not limited to, a challenging
market within the Contract and Branded sales divisions as well as
the Group's own decision to divest from non-profitable product
offerings that do not achieve a commercially viable contribution
margin.
|
Year ended
31 March
2024
|
Year ended
31 March
2023
|
|
£000
|
£000
|
Revenue
|
53,194
|
58,567
|
Gross profit
|
22,830
|
24,348
|
Gross profit %
|
42.9%
|
41.6%
|
Operating profit before exceptional
items
|
1,538
|
1,584
|
Operating profit margin % before
exceptional items
|
2.9%
|
2.7%
|
Exceptional items
|
(4,466)
|
(477)
|
Finance Costs
|
(349)
|
(420)
|
(Loss) / Profit before tax
|
(3,277)
|
687
|
(Loss) / Profit after tax
|
(3,527)
|
514
|
EBITDA
|
3,239
|
3,001
|
Adjusted Diluted EPS - excluding
exceptional items
|
1.42
pence
|
1.05
pence
|
Cash and cash equivalents
|
3,138
|
1,653
|
Inventories
|
8,225
|
10,228
|
The on-going challenging
macro-economic environment, within which the business operates,
resulted in inflationary pressures across the cost of labour, raw
materials, componentry, and commodity prices. This had the impact
of eroding Gross profit margins. The Group has responded well to
managing these external pressures by adopting processes to monitor
Cost Price Increase (C.P.I) across all categories of supply. This
allowed the Group to be pro-active and combat areas of eroding
margins. Actions taken included product re-engineering,
re-formulating, and increasing customer selling prices. The impact
of this has led to the Group improving its Gross profit margin by
1.3% to 42.9% (2023: 41.6%).
As the sales activity and in turn the
manufacturing output across the Group has reduced year on year, the
Group has had to implement a strategy of cost rationalisation to
allow it to re-align its overhead base with the current level of
activity. This had the impact of reducing direct and in-direct
labour costs, administrative expenses and warehousing and
distributions costs. Manufacturing efficiencies have also aided
with the streamlining of both cost of sales and overhead costs. As
a result of this, the operating profit before exceptional items
decreased marginally £0.1m from the previous year despite a revenue
reduction of £5.4m.
As a direct result of the strong
operating performance, the business has been able to generate £3.2m
of EBITDA ( before exceptional items - Impairment) in the year to
March 2024 (2023: £3.0m). This has equated to an increase in cash
generated from operating activities by £0.2m to £6.1m from £5.9m.
The Group has utilised the cash to reduce its debt exposure with
net gearing reducing by 18.6% to 3.5% (2023: 22.1%). Net cash on
hand has increased by £3.4m to positive £2.2m (2023: negative
£1.2m). Please refer to the section on Key Performance Indicators
on page 17 of the full accounts
where they are defined.
Revenue
Overall Group sales were £53.2m for
the year ended March 2024 (2023: £58.6m) a reduction of
£5.4m.
The sales generated by each revenue
stream are;
|
2024
|
2023
|
Movement
|
|
£000's
|
£000's
|
|
Branded products
|
21,020
|
22,757
|
Decrease of 7.6%
|
Private label
|
23,727
|
21,997
|
Increase of 7.9%
|
Contract manufacturing
|
8,431
|
13,795
|
Decrease of 38.9%
|
Other
|
16
|
18
|
Decrease of 11.1%
|
Total
|
53,194
|
58,567
|
Decrease of 9.2%
|
Please refer to the Managing
Director's statement on Revenue movements.
Margin and cost of sales
The Group implemented systems and
processes to monitor Cost Price Increase (C.P.I) across all
categories of supply. These included but were not limited to;
plastics, raw materials, energy, wage inflation and transport
(global and domestic) costs. Gross margin was 42.9% for the year
ended 31 March 2024 (2023: 41.6%). Gross margin has improved in the
second half of the year to 43.7%, compared to the first half 42.2%
due to proactive measures taken by management in the areas of
customer price increases, cost mitigation and product
re-engineering and reduced labour costs due to shift
rationalisation and efficiency improvements. Additionally, the
business has reviewed its product portfolio and ensured SKU's not
achieving the desired level of contribution margin were
exited.
Distribution costs and Administrative
expenses
Distribution costs have decreased by
10.6% to £3.5m (2023: £3.9m) at a faster rate than the reduction in
revenue. This is due to a combination of factors, primarily as a
result of the reduction in manufacturing volumes and complimented
by the decision to exit third-party logistics providers and
bringing picking and packing of finished goods in house. Underlying
net costs associated with outsourcing the warehousing and
third-party storage have decreased by £0.4m year on year. A phased
approach was undertaken to ensure consistency of supply and service
levels with the majority of the savings being realised in the
second half of the year. This has had a positive impact on both
costs and the efficiencies of the business going
forward.
Administrative expenses have
decreased by 5.6% to £17.8m in the year (2023: £18.9m). The
reduction in costs have largely been driven by a combination of
cost rationalisation and reduced business activity.
Manufacturing efficiencies have been enhanced
whilst not compromising on customer delivery. The efficient
utilisation of the factory along with the decrease in units sold
has meant that utility costs have reduced by £0.3m to £0.7m (2023:
£1.0m). Overhead savings have been achieved across most cost
headings including indirect payroll. A huge
driver of the decrease in overheads was the full year impact of the
decision made to move to a single shift. This has not had an impact on the output of the factory and
thus has not impacted on the ability to meet customer
demand.
Operating profit before exceptional costs
Operating profit before exceptional
costs was marginally reduced year on year to £1.5m (2023: £1.6m).
The small reduction is a direct result of the improvement in the
gross profit margin despite the decline in revenue. Strategic sales
price increases that balance competitiveness with profitability
have positively impacted the operating profit margin. Customer
price increases have improved the gross profit margin.
Additionally, the Group has been efficient in the management of its
operating costs relative to its revenue. As a result, a greater
percentage of revenue is translated into profit after
covering operating expenses. Operating profit
margin before exceptional costs increased to 2.9% (2023:
2.7%).
Exceptional items
Redundancy costs of £0.02m have been
incurred in the year to March 2024. In the previous year,
redundancy costs incurred of £0.17m were in respect of the closure
of the second shift at Peterborough.
As reported in September 2022 there
was an additional charge in respect of the acquisition of the Emma
Hardie business should the Company's share price fail to attain
£1.25 on the first anniversary of the sale. The excess over the
amount paid at 31 March 2022 amounted to £0.31m and was treated as
an exceptional cost in the year to March 2023. No additional costs
in relation to this have been incurred in the year to March
2024.
As required by IAS 36, the Group
reassesses its capitalised intangible assets for impairment on an
annual basis. Following the difficult trading years of the Emma
Hardie subsidiary, management have assessed that the brand value
acquired on acquisition in relation to Emma Hardie has been
impaired by £4.4m. This is shown as a separate line item in the
Consolidated profit and loss account as it is an expense that is
not in line with the normal trading operations of the Group. The
impact of this impairment is not cash impacting and is an entry
that reduces the intangible assets (Brand value for Emma Hardie) on
the balance sheet with a corresponding entry in the Consolidated
income statement. The associated goodwill and deferred tax
liability was derecognised from the balance sheet. Please
refer to notes 3, 8, 13 and note 14 of the full
accounts.
EBITDA before exceptional items
The Group has generated Earnings
before Interest, Tax, Depreciation and Amortisation (EBITDA) of
£3.2m (2023: £3.0m). This represents an increase of £0.2m despite
lower revenue achieved in the year to March 2024.
Tax
The Group has a corporation tax
charge of £0.3m (2023: £0.2m). The Group finalised an over
provision of the tax charge in the previous year in relation to an
under provision of the enhanced R&D relief.
(Loss) / Profit after tax
The Group reported a loss after tax
of £3.5m for the year ended 31 March 2024 (2023: Profit
£0.5m).
Earnings per share
The diluted earnings per share
decreased to negative 5.15p (2023: positive 0.65p).
Share options are excluded from the earnings per
share calculation in the consolidated income statement due to their
anti-dilutive effect on the loss after tax attributable to equity
holders. The EPS has been adversely impacted by the reduction in
profit after tax including the exceptional costs of £4.4m (2023:
£0.5m). The main exceptional item in the current year pertaining to
the brand impairment of Emma Hardie is a non-cash impacting item.
Adjusted diluted earnings per share excluding exceptional items for
the year were positive 1.42p (2023: 1.05p).
Research and development
The Group undertakes significant
research and development (R&D) to identify new brands,
proprietary products and improved formulations to existing products
that address expected market trends to maximise the Group's market
share and deliver new opportunities for growth. The spend in the
year on research and development was £753,000 (2023:
£923,000).
The Group's principal focus in
R&D is maintenance and development of brands and products in
its existing markets and product ranges. As our brands evolve the
Group now develops ranges which involve greater innovative
development and claims substantiation which has changed the nature
of our research and development over recent years. One impact of
this development is improved claims for research and development
tax relief.
Cash on hand and working capital
Net cash on hand (cash and cash
equivalents less short-term element of obligations under finance
leases and borrowings) is positive £2.2m (2023: negative £1.2m).
The improvement in cash of £3.4m year on year is mainly
attributable to continued improvements in profit from operations,
reduction in inventory and working capital.
Stock
Stock reductions of £2.0m were
achieved during the year to March 2024. This was achieved by a
targeted reduction in purchasing quantities and manufacturing batch
sizes to reduce stock holding on both raw materials and finished
goods. The reduction in stock levels was a key factor in enabling
the transfer of finished goods from third-party warehousing to the
main site in Peterborough.
Return on Capital Employed
The small increase in operating
profit before exceptional items coupled with the decrease in net
equity and the substantial reduction in borrowings has improved
return on capital employed by 1.6% from 4.3% to 5.9% (see page
17 of the full accounts). This is in line with the Group's objective to provide a
stable base for growth. The Group continues to look for
opportunities to invest in brands that will help drive faster
growth in profits.
Net
gearing
With the increase in cash generation
and reduction in cash outflow the business was able to utilise the
cash generated to improve its liquidity by reducing its reliance on
short term borrowings. Additionally, the Group has reduced its
gearing by making an overpayment in March 2024 to pay down half of
the term loan outstanding at the year end. The Net gearing of 3.5%
(2023: 22.1%) has decreased by 18.6% percentage points in the
year.
Dividend
The Director's propose a final
dividend for the year ended 31 March 2024 of 0.45 pence per
ordinary share (2023: nil). The Group has exhibited strong
operational performance and generated cash which in turn has
improved the Group's liquidity and reduced its gearing. This is
consistent with the Directors' objective to align future dividend
payments to the future underlying earnings and cash requirements of
the business. The total dividend paid in the year ended 31 March
2024 was nil (2023: nil) per ordinary share.
Directors'
responsibilities statement
The Directors whose names
and functions are set out on page 112 of the full accounts are responsible
for preparing the Annual Report and the Financial Statements in
accordance with applicable law and
regulation.
Company law requires the
Directors to prepare financial statements for each financial year.
Under that law the Directors have prepared the Group financial
statements in accordance with UK-adopted international accounting
standards and parent Company financial statements in accordance
with United Kingdom Generally Accepted Accounting Practice (United
Kingdom Accounting Standards, comprising FRS 101 'Reduced
Disclosure Framework', and applicable law). Under Company law
the Directors must not approve the financial statements unless they
are satisfied that they give a true and fair view of the state of
affairs of the Company and the Group and of the profit or loss of
the Group for that period. In preparing these financial statements,
the Directors are required to:
· select
suitable accounting policies and then apply them
consistently;
· state
whether UK-adopted international accounting standards have been
followed for the group financial statements and United Kingdom
Accounting Standards, comprising FRS 101, have been followed for
the Company financial statements, subject to any material
departures disclosed and explained in the financial
statements;
· make
judgements and accounting estimates that are reasonable and
prudent; and
· prepare the financial statements on the going concern basis
unless it is inappropriate to presume that the Company will
continue in business.
The Directors are responsible for
safeguarding the assets of the Group and parent Company and hence
for taking reasonable steps for the prevention and detection of
fraud and other irregularities.
The Directors are responsible for
keeping adequate accounting records that are sufficient to show and
explain the Group and parent Company's transactions and disclose
with reasonable accuracy at any time the financial position of the
Group and parent Company and enable them to ensure that the
financial statements and the Directors' Remuneration Report
comply with the Companies Act 2006.
The Directors are responsible for
the maintenance and integrity of the parent Company's website.
Legislation in the United Kingdom governing the preparation and
dissemination of financial statements may differ from legislation
in other jurisdictions.
Directors' confirmations
The Directors consider that the
Annual Report and accounts, taken as a whole, is fair, balanced and
understandable and provides the information necessary for
shareholders to assess the group and parent Company's position and
performance, business model and strategy. Each of the Directors,
whose names and functions are listed in Directors and Advisers on
page 112 of the full accounts confirm that to the best of their
knowledge:
1. the parent Company
financial statements, which have been prepared in accordance with
United Kingdom Generally Accepted Accounting Practice (United
Kingdom Accounting Standards, comprising FRS 101 'Reduced
Disclosure Framework', and applicable law), give a true and fair
view of the assets, liabilities, financial position and profit of
the Company; and
2. the group financial
statements, which have been prepared in accordance with UK-adopted
international accounting standards, give a true and fair view of
the assets, liabilities, financial position and profit of the
group; and
3. the strategic report
includes a fair review of the development and performance of the
business and the position of the Company and the undertakings
included in the consolidation taken as a whole, together with the
description of the principal risks and uncertainties that they
face; and
4. the report and
financial statements, taken as a whole, are fair, balanced and
understandable and provide the information necessary for
shareholders to assess the Group's position and performance,
business model and strategy.
Principal risks and
uncertainties
The Board regularly monitors
exposure to key risks, such as those related to production
efficiencies, cash position and competitive position relating to
sales. It has also taken account of the risks facing the business
from the challenging economic environment including inflationary
pressures, higher interest rates and their impact on consumer
demand. Further details of mitigating measures taken by management
are set out on page 2 of the full accounts.
It also monitors risks not directly
or specifically financial, but capable of having a major impact on
the business's financial performance if there is any failure. The
key risks and the measures taken to manage these risks are noted
below.
Capital structure, cash flow and liquidity
The Group has a strong balance
sheet. The business is funded using; retained earnings, a long term
mortgage, term loan and sale and lease back arrangements to support
investments in fixed assets, invoice financing and overdraft
facilities for working capital. Further details are set out in
notes 23 and 24 of the full
accounts.
At 31 March 2024 the invoicing financing is in a surplus position
of £6,100 as the facility is not being utilised. The operations
have generated sufficient cash to improve its liquidity. In the
year to 31 March 2023 the facility was utilised to fund the
activities during the year (2023: £1,557,000). At 31 March 2024 the
Group has utilised its overdraft facility by £37,000 (2023:
£26,000). Further details are set out in note 21 in relation to
cashflow and liquidity risk of the full
accounts.
Competitive environment
The Group operates in a highly
competitive environment in which demand for products can vary and
customers have the opportunity to transfer business to other
suppliers. The Group works to minimise this risk by developing
close relationships with customers offering quality, service and
innovation throughout the business. This risk is also further
reduced through the development of its branded product portfolio
and by the diversity of customers and products offered. All
customers are credit insured or pay on proforma basis before
supply.
Quality and Safety
The Group treats quality as its key
requirement for all products and strives to deliver performance
products for every price point. Failure to achieve the required
quality and safety standards would have severe consequences for the
Group, from financial penalties to the damage to customer
relationships. The Group has a robust product development process
to mitigate risk wherever possible and to ensure all products are
safe and fit for purpose. The Group is
subject to frequent internal and external safety, environmental,
ethical and quality audits covering both accreditations held and a
number of specific operating standards our customers require us to
comply with.
Global economic environment
The cost-of-living crisis in the
U.K. continues to abate consumer demand. The Group strategy of
pursuing a multi-channel approach to the market and a broad
multi-category product offering continues to serve us well during
times when consumer demand is impacted by a cost-of-living
crisis.
The BOE base interest rates have
increased by 1.25% to 5.25% in response to inflationary pressures.
This has had a negative impact on consumer demand and the viability
of many businesses. The rate of increase in commodities has eased
in the second half of the current financial year but core domestic
inflation and the prospect of prolonged higher interest rates
remains a cause for concern. The rate of domestic inflation has
reduced but not to the levels expected which has meant the BOE have
held their base rate. Please see note 21 of
the full accounts for impact of interest
sensitivity on our current level of gearing.
The global supply chain continues to
be impacted by the war in Ukraine and the Red Sea issues due to the
ongoing conflict in the Middle East. The cost of importation of
goods has increased as well as delivery lead times. These continue
to be closely managed by working collaboratively with our supply
base.
The Group monitors C.P.I's across
all categories of supply. Mitigation
measures included product re-engineering, re-formulating, and
increasing customer selling prices where appropriate.
The Directors have taken account of
these potential impacts in their going concern assessments and have
concluded that the direct impact is not significant to the
business, with the indirect impact of price increases being
reviewed on a regular basis. In the face of these challenges the
focus of the business will be on positive cash generation and
restoration of profitability.
Credit risk
Our credit risk is that our
customers are unable to pay, and we believe this risk is elevated
currently due to the current global economic climate. We
proactively manage the risks faced by our customers by working
closely with them and by increasing debtor management and expanding
our credit insurance. All customers' debtor balances, are within
insured credit limits or they pay on a pro-forma basis. Credit
control processes are in place to manage credit risk including
setting appropriate credit limits and the enforcement of credit
terms and ongoing dialogue with all customers. We minimise the risk
from concentration of customers through implementation of these
credit processes and this risk is mitigated through the diversity
of our customer base both by channel and geography. We remain
vigilant to the credit risks in light of the challenging economic
environment.
Supplier sourcing and
costs
Cost increases as a result of
inflation together with pressures on supply of materials globally
are our key supplier-related risks. The pressure on global supply
chains has eased but there remains uncertainty around future
commodity pricing. We continue to work closely with suppliers and
have used our improved sourcing capabilities to expand our supply
base to ensure that we can meet the demand from our existing and
new customers and minimise the impact of cost price increases. We
have an ongoing dialogue and communication with our customers to
mitigate the impact on the business.
Environmental protection standards and
sustainability
The Group's technical department
continues to monitor all relevant environmental regulations that
the Group must adhere to, to ensure continued compliance. We have
successfully operated at both manufacturing sites without a
cessation in production due to an environmental incident. The risk
of cessation of production from an environmental breach is
considered to be low but in such an event we would be able to move
production to the other site or to outsource to third party
manufacturers in the short term.
The Group's objective is to keep
ahead of the move towards more sustainable products and processes.
There is a risk that if we do not take action we will be left
behind and unable to meet our customers' requirements. However, the
Group sees the move towards sustainability as an opportunity for
business growth.
Cyber security
Cyber Security remains a significant
threat to all businesses. The Group is exposed to the risk of
sophisticated cyber-attacks aimed at causing direct financial loss
from theft of funds, ransom payments, and costs associated with
system recovery and data restoration. Such attacks also lead to
business interruption, causing lost productivity and revenue. There
is also a heightened risk of theft and encryption of confidential
data for financial gain and reputational damage.
The Group has continued to invest in
new software and resources to minimise the risk of anyone accessing
our systems and information. We have enhanced our ongoing training
programme for employees to ensure that they are constantly aware of
their role in protecting the business from all cyber security
threats. The Group has an insurance policy in place to minimise its
exposure to cybercrime.
Consolidated income statement
|
|
Year ended 31 March
2024
|
Year ended 31 March
2023
|
|
|
£000
|
£000
|
Revenue
|
|
53,194
|
58,567
|
Cost of sales
|
|
(30,364)
|
(34,219)
|
Gross profit
|
|
22,830
|
24,348
|
|
|
|
|
Distribution costs
|
|
(3,488)
|
(3,902)
|
Administrative expenses
|
|
(17,804)
|
(18,862)
|
Operating profit before exceptional
items
|
|
1,538
|
1,584
|
|
|
|
|
Exceptional items - Redundancy
costs
|
|
(17)
|
(165)
|
Exceptional items -
Impairment
|
|
(4,449)
|
-
|
Operating profit
|
|
(2,928)
|
1,419
|
|
|
|
|
Exceptional items - Acquisition
costs
|
|
-
|
(312)
|
Finance costs
|
|
(349)
|
(420)
|
Profit before tax
|
|
(3,277)
|
687
|
|
|
|
|
Taxation
|
|
(250)
|
(173)
|
(Loss) / Profit for the year
attributable to the equity shareholders
|
|
(3,527)
|
514
|
Consolidated statement of comprehensive
income
|
|
Year ended
31 March
2024
|
Year ended
31 March
2023
|
|
|
£000
|
£000
|
(Loss) / Profit for the
year
|
|
(3,527)
|
514
|
Items that may be subsequently reclassified to profit and loss:
|
|
|
|
Exchange differences on translating
foreign operations
|
|
13
|
(9)
|
Other comprehensive income for the
year
|
|
13
|
(9)
|
|
|
|
|
Total comprehensive income for the
year attributable to the equity shareholders
|
|
(3,514)
|
505
|
Earnings per share
|
|
Year ended 31
March
|
Year ended 31
March
|
|
Note
|
2024
|
2023
|
Basic
|
5
|
(5.15p)
|
0.74p
|
Diluted *
|
5
|
(5.15p)
|
0.65p
|
* Share options are excluded from the
earnings per share calculation for the year ended 31 March 2024 due
to their anti-dilutive effect on the loss after tax attributable to
equity holders.
Adjusted Earnings per
share - alternate performance measure
The following calculation of the
basic and diluted earnings per share excluding exceptional items
has been calculated based on adding back the following deductions
from (loss) / profit after tax:
|
|
Year ended
31-Mar
|
Year ended
31-Mar
|
|
|
2024
|
2023
|
|
|
£000
|
£000
|
(Loss) / Profit for the period from
operations attributable to the equity shareholders of the parent
Company
|
|
(3,527)
|
514
|
Exceptional items -
Impairment
|
|
4,449
|
-
|
Exceptional items - Deferred tax
charge not previously recognised
|
|
165
|
-
|
Exceptional items - Acquisition costs
(disallowed for tax provision)
|
|
-
|
312
|
Adjusted Earnings excluding
exceptional items
|
|
1,087
|
826
|
Adjusted Basic earnings per share -
excluding exceptional items
|
|
1.59p
|
1.19p
|
Adjusted Diluted earnings per share -
excluding exceptional items
|
|
1.42p
|
1.05p
|
Dividends
|
Year ended
31-Mar
|
Year ended
|
31-Mar
|
|
2024
|
2023
|
|
£000
|
£000
|
Final dividend paid - £Nil (2023:
£Nil) per share
|
-
|
-
|
Interim dividend paid £Nil
(2023: £Nil) per share
|
-
|
-
|
Total dividend paid in year - £Nil
(2023: £Nil) per share
|
-
|
-
|
Proposed - 0.45 pence (2023: Nil) per
share
|
315
|
-
|
Consolidated balance sheet
|
|
31 March
|
31 March
|
|
|
2024
|
2023
|
|
Note
|
£000
|
£000
|
Non-current assets
|
|
|
|
Goodwill
|
|
1,575
|
2,857
|
Other intangible assets
|
|
6,374
|
10,894
|
Property, plant and
equipment
|
|
5,219
|
5,890
|
Right-of-use assets
|
|
1,093
|
1,285
|
|
|
14,261
|
20,926
|
Current assets
|
|
|
|
Inventories
|
|
8,225
|
10,228
|
Trade and other
receivables
|
|
10,518
|
12,733
|
Cash and cash equivalents
|
|
3,138
|
1,653
|
|
|
21,881
|
24,614
|
|
|
|
|
Total assets
|
|
36,142
|
45,540
|
|
|
|
|
Current liabilities
|
|
|
|
Trade and other payables
|
|
8,265
|
9,836
|
Corporation tax payable
|
|
105
|
3
|
Lease liabilities
|
|
351
|
373
|
Borrowings
|
|
620
|
2,502
|
|
|
9,341
|
12,714
|
|
|
|
|
Net
current assets
|
|
12,540
|
11,900
|
|
|
|
|
Non-current liabilities
|
|
|
|
Deferred tax liability
|
|
1,798
|
2,942
|
Lease liabilities
|
|
633
|
917
|
Borrowings
|
|
2,315
|
3,488
|
|
|
4,746
|
7,347
|
|
|
|
|
Total liabilities
|
|
14,087
|
20,061
|
|
|
|
|
Net
assets
|
|
22,055
|
25,479
|
|
|
|
|
Equity
|
|
|
|
Share capital
|
|
700
|
700
|
Share premium account
|
|
2,024
|
2,022
|
Merger reserve
|
|
2,476
|
2,476
|
Treasury shares
|
|
(576)
|
(576)
|
Other reserves
|
|
(211)
|
(211)
|
Translation reserve
|
|
27
|
14
|
Retained earnings
|
|
17,615
|
21,054
|
Total equity attributable to the equity shareholders of the
parent Company
|
|
22,055
|
25,479
|
Consolidated statement of changes in equity
|
Share capital (note
6)
|
Share premium
account
|
Merger
reserve
|
Treasury
Shares
|
Other
reserves
|
Translation
reserve
|
Retained
earnings
|
Total
equity
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
At 1 April 2022
|
697
|
1,951
|
2,476
|
-
|
(211)
|
23
|
20,742
|
25,678
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the year
|
|
|
|
|
|
|
|
|
Profit for the year
|
-
|
-
|
-
|
-
|
-
|
-
|
514
|
514
|
Exchange differences on translation
of foreign operations
|
-
|
-
|
-
|
-
|
-
|
(9)
|
-
|
(9)
|
Total comprehensive income for the year
|
-
|
-
|
-
|
-
|
-
|
(9)
|
514
|
505
|
|
|
|
|
|
|
|
|
|
Contributions by and distributions to owners
|
|
|
|
|
|
|
|
|
Exercise of options
|
3
|
71
|
-
|
-
|
-
|
-
|
-
|
74
|
Purchase of own
shares
|
-
|
-
|
-
|
(576)
|
-
|
-
|
-
|
(576)
|
Share-based payment charge
|
-
|
-
|
-
|
-
|
-
|
-
|
101
|
101
|
Deferred tax through
Equity
|
-
|
-
|
-
|
-
|
-
|
-
|
(303)
|
(303)
|
Total contributions by and distributions to
owners
|
3
|
71
|
-
|
(576)
|
-
|
-
|
(202)
|
(704)
|
|
|
|
|
|
|
|
|
|
At
31 March 2023
|
700
|
2,022
|
2,476
|
(576)
|
(211)
|
14
|
21,054
|
25,479
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the year
|
|
|
|
|
|
|
|
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,527)
|
(3,527)
|
Exchange differences on translation
of foreign operations
|
-
|
-
|
-
|
-
|
-
|
13
|
-
|
13
|
Total comprehensive loss for the year
|
-
|
-
|
-
|
-
|
-
|
13
|
(3,527)
|
(3,514)
|
|
|
|
|
|
|
|
|
|
Contributions by and distributions to owners
|
|
|
|
|
|
|
|
|
Exercise of options
|
-
|
2
|
-
|
-
|
-
|
-
|
-
|
2
|
Share-based payment charge
|
-
|
-
|
-
|
-
|
-
|
-
|
111
|
111
|
Deferred tax through
Equity
|
-
|
-
|
-
|
-
|
-
|
-
|
(23)
|
(23)
|
Total contributions by and distributions to
owners
|
-
|
2
|
-
|
-
|
-
|
-
|
88
|
90
|
|
|
|
|
|
|
|
|
|
At
31 March 2024
|
700
|
2,024
|
2,476
|
(576)
|
(211)
|
27
|
17,615
|
22,055
|
Consolidated cash flow statement
|
|
Year ended 31
March
|
Year ended 31
March
|
|
|
2024
|
2023
|
|
Note
|
£000
|
£000
|
Profit from operations including redundancy
costs
|
|
1,521
|
1,419
|
|
|
|
|
Adjustments for:
|
|
|
|
Depreciation on property, plant and
equipment
|
|
992
|
1,000
|
Depreciation on right of use
assets
|
|
368
|
294
|
Amortisation of intangible
assets
|
|
358
|
288
|
Loss/(Profit) on disposal of Right of
Use assets
|
|
59
|
34
|
Share based payment charge
|
|
111
|
101
|
|
|
3,409
|
3,136
|
|
|
|
|
Decrease in inventories
|
|
2,003
|
2,250
|
Decrease in trade and other
receivables
|
|
2,215
|
776
|
(Decrease) in trade and other
payables
|
|
(1,570)
|
(288)
|
Cash
generated from operations
|
|
6,057
|
5,874
|
|
|
|
|
Taxation paid
|
|
(30)
|
(62)
|
Net
cash generated from operating activities
|
|
6,027
|
5,812
|
|
|
|
|
Investing activities
|
|
|
|
Purchase of property, plant and
equipment
|
|
(321)
|
(825)
|
Purchase of intangible
assets
|
|
(287)
|
(315)
|
Acquisition of Brodie &
Stone
|
|
-
|
(75)
|
Acquisition of Emma Hardie
|
|
-
|
(1,424)
|
Net
cash used in investing activities
|
|
(608)
|
(2,639)
|
|
|
|
|
Financing activities
|
|
|
|
Proceeds on issue of
shares
|
|
2
|
74
|
Cancellation of leases
|
|
(59)
|
(35)
|
Principal paid on lease
liabilities
|
|
(568)
|
(436)
|
Utilisation of invoice financing
facilities
|
|
-
|
290
|
Repayment of invoice financing
facilities
|
7
|
(1,557)
|
-
|
Repayment of amounts
borrowed
|
7
|
(61)
|
(600)
|
Repayment on term loan
|
7
|
(1,329)
|
(816)
|
Interest paid on term loan
|
7
|
(123)
|
-
|
Repayment on mortgage loan
facility
|
7
|
(180)
|
(252)
|
Interest paid on mortgage loan
facility
|
7
|
(72)
|
-
|
Purchase of shares - Share buy
back
|
|
-
|
(576)
|
Net
cash generated (used in) financing activities
|
|
(3,947)
|
(2,351)
|
|
|
|
|
Net
increase in cash and cash equivalents
|
|
1,472
|
822
|
|
|
|
|
Cash and cash equivalents at start of
year
|
|
1,653
|
840
|
Effect of foreign exchange rate
changes
|
|
13
|
(9)
|
|
|
|
|
Cash
and cash equivalents at end of year
|
|
3,138
|
1,653
|
Notes to
preliminary announcement
1. Significant accounting
policies
Basis of accounting
The
Group financial statements have been prepared in accordance with
UK-adopted international accounting standard in conformity with the
requirements of the Companies Act 2006.
The IFRSs applied in the
Group financial statements are subject to ongoing amendment by the
IASB and therefore subject to possible change in the future.
Further standards and interpretations may be issued that will be
applicable for financial years beginning on or after 1 April 2024
or later accounting periods but may be adopted
early.
The preparation of
financial statements in accordance with IFRS requires the use of
certain accounting estimates. It also requires management to
exercise its judgement in the process of applying the Group's
accounting policies.
The primary statements
within the financial information contained in this document have
been presented in accordance with IAS1 Presentation of Financial
Statements.
The financial statements have been
prepared on the historical cost basis as modified for the fair
value of business combinations. Historical cost is generally based
on the fair value of the consideration given in exchange for goods
and services. The principal accounting policies adopted are set out
below.
The Company has taken advantage of
the exemption allowed under section 408 of the Companies Act 2006
and has not presented its own Statement of Comprehensive Income in
these financial statements.
Adoption of new and revised accounting
standards
None of the standards adopted
during the year had a material impact on the Group's financial
statements for the year ended 31 March 2024.
There are a number of standards,
amendments to standards, and interpretations which have been issued
by the IASB that are effective in future accounting periods that
the Group has decided not to adopt early. The Group does not expect
any of the standards issued by the IASB, but not yet effective, to
have a material impact on the Group.
2. Financial instruments and treasury risk
management
Market risk
Market risk is the risk that arises
from movements in stock prices, interest rates, exchange rates, and
commodity prices.
Market risk for the 31 March 2024
year end is reflected within the interest rate and foreign currency
risk which are discussed further below.
Credit risk
Credit risk is the risk of
financial loss to the Group if a customer fails to meet its
contractual obligations.
Trading exposures are monitored by
the operational companies against agreed policy levels. Credit
insurance with a world leading insurer is employed across the
majority of our trade debtors. At 31 March 2024 all trade
debtors (2023: all) are covered by credit insurance with a cover of
90% of the debtor balances. Non-trading financial exposures are
incurred only with the Group's bankers or other institutions with
prior approval of the Board of Directors.
The majority of trade receivables
are with retail customers. The maximum exposure to credit risk is
represented by the carrying amount of those financial assets in the
balance sheet.
Impairment provisions on trade
receivables have been disclosed in note 19 of the full accounts.
The credit risk on liquid funds
such as cash and cash equivalents is limited because the
counterparties are banks
with high credit-ratings assigned
by international credit-rating agencies.
All trade debtors are credit
insured, therefore the maximum write off balance on any customer
default would be 10% of the invoiced value (net of VAT).
Interest rate risk
The Group's interest rate exposure
arises mainly from its interest-bearing borrowings.
The Group finances its operations
through a mixture of debt associated with working capital
facilities and equity. The Group is exposed to changes in
interest rates on its floating rate working capital facilities. The
variability and scale of these facilities is such that the Group
does not consider it cost effective to hedge against this
risk.
The Group also secured a fixed rate mortgage for a 15
year term, 10.5 years remaining, secured on the property with an
interest rate of 3.04% fixed for the first 10 years, 5.5 years
remaining, of the loan, therefore reducing the interest rate risk.
The interest charge on the mortgage for the year ended 31 March
2024 was £72,000 (2023: £77,000).
On 3 September 2021, the Group took
out a term loan of £3,000,000 to fund part of the purchase of the
acquisitions in the prior year. The term loan is for a 4 year term
secured on the assets of the Group with an interest rate of 2.70%
above the Bank of England base rate. The interest charge on the
term loan for the period to 31 March 2024 was £123,000 (2023:
£111,000). A 1% increase in the interest rate would have resulted
in an additional charge of £41,000 (2023: £22,000).
Interest rate sensitivity
The interest rate sensitivity is
based upon the Group's borrowings over the year assuming a 1%
increase or decrease which is used when reporting interest rate
risk internally to key management personnel.
A 1% increase in bank base rates
would reduce Group pre-tax profits by £36,000 (2023: £114,000). A
1% decrease would have the opposite effect. The Group's sensitivity
to interest rates has changed during the current year due to the
current economic climate, which has had the impact of increasing
BOE base rates.
Foreign currency risks
The Group operates in a number of
markets across the world and is exposed to foreign currency
transaction and translation risks arising on the purchase and sales
of goods in particular with respect to the US dollar and Euro.
Transaction risk arises on income
and expenditure in currencies other than the functional currency of
each Group Company. The
magnitude of this risk is relatively low as the majority of the
Group's income and expenditure are denominated in the functional
currency. Approximately 1% (2023: 0%) of the Group's income is
denominated in US dollars and 4% (2023: 2%) in Euros. Approximately
7% (2023: 4%) of the Group's expenditure is denominated in US
dollars and 8% (2023: 4%) in Euros.
Foreign currency sensitivity
A 5% strengthening of sterling
would result in a £258,000 (2023: £145,000) increase in profits and
equity. A 5% weakening in sterling would result in a £285,000
(2023: £161,000) reduction in profits and equity.
When appropriate the Group utilises
currency derivatives to hedge against significant future
transactions and cash flow. There were no outstanding contracts as
at 31 March 2024 or 31 March 2023.
Cash flow and liquidity risk
Liquidity risk arises from the
Group's management of working capital. It is the risk that the
Group will encounter difficulty in meeting its financial
obligations as they fall due.
The Group manages its working
capital requirements through overdrafts and invoice finance
facilities. These facilities were renewed in March 2024 for a
further 12 months. The maturity profile of the committed bank
facilities is reviewed regularly and such facilities are extended
or replaced well in advance of their expiry. The Group has complied
with the terms of these facilities. At 31 March 2024 the Group had
available £5,616,000 (2023: £4,327,000) of undrawn committed
borrowing facilities in respect of which all conditions precedent
had been met. The Group has a fixed rate mortgage
for a 15 year term secured on the property with an
interest rate of 3.04% fixed for the next 5.5 years of the loan.
The Company also took out a term loan of £3,000,000 to fund part of
the purchase of the acquisitions in the prior year. The term loan
is for a 4 year term secured on the assets of the Group with an
interest rate of 2.70% above the Bank of England base
rate.
3. Financial assets
Financial assets are included in
the Statement of financial position within the following headings.
These are valued at amortised cost and are detailed
below.
|
Group
|
|
2024
|
2023
|
|
£000
|
£000
|
|
|
|
Trade and other receivables
|
10,172
|
12,220
|
Cash and cash equivalents
|
3,138
|
1,653
|
|
|
|
Total
|
13,310
|
13,873
|
4. Financial liabilities
Financial liabilities are included
in the Statement of financial position within the following
headings. These are valued at amortised cost and are detailed
below.
At 31 March 2024
|
Group
|
|
Less than 6
months
|
Between 6 months and 1
year
|
Between 1 and 5
years
|
Over 5
years
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£'000
|
|
|
|
|
|
|
Trade payables
|
4,976
|
-
|
-
|
-
|
4,976
|
Accruals
|
2,235
|
-
|
-
|
-
|
2,235
|
Obligations under leases
|
182
|
169
|
633
|
-
|
984
|
Overdraft and invoice
financing
|
37
|
-
|
-
|
-
|
37
|
Loan
|
286
|
297
|
1,017
|
1,298
|
2,898
|
|
|
|
|
|
|
Total
|
7,716
|
466
|
1,650
|
1,298
|
11,130
|
At 31 March 2023
|
Group
|
|
Less than 6
months
|
Between 6 months and 1
year
|
Between 1 and 5
years
|
Over 5
years
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£'000
|
|
|
|
|
|
|
Trade payables
|
5,974
|
-
|
-
|
-
|
5,974
|
Accruals
|
2,723
|
-
|
-
|
-
|
2,723
|
Obligations under leases
|
194
|
179
|
874
|
43
|
1,290
|
Overdraft and invoice
financing
|
1,583
|
-
|
-
|
-
|
1,583
|
Loan
|
453
|
466
|
1,977
|
1,511
|
4,407
|
|
|
|
|
|
|
Total
|
10,927
|
645
|
2,851
|
1,554
|
15,977
|
5. Earnings per share
The calculation of the basic and
diluted earnings per share is based on the following
data:
|
Year ended
31-Mar
|
Year ended
31-Mar
|
|
2024
|
2023
|
|
£000
|
£000
|
Earnings
|
|
|
(Loss) / profit attributable to the
equity holders of the parent Company
|
(3,527)
|
514
|
|
Year ended
31-Mar
|
Year ended
31-Mar
|
|
2024
|
2023
|
|
Number
|
Number
|
Number of shares
|
|
|
Weighted average number of ordinary
shares for the purposes of basic earnings per share
|
68,433,858
|
69,166,461
|
|
|
|
Effect of dilutive potential ordinary
shares relating to share options *
|
8,310,548
|
9,534,475
|
|
|
|
Weighted average number of ordinary
shares for the purposes of Adjusted Earnings per share (2023: for
the purpose of Diluted Earnings per share)
|
76,744,406
|
78,700,936
|
Basic earnings per share - including
exceptional items
|
(5.15p)
|
0.74p
|
Diluted earnings per share -
including exceptional items *
|
(5.15p)
|
0.65p
|
* Share options are excluded from
the earnings per share calculation for the year ended 31 March 2024
due to their anti-dilutive effect on the loss after tax
attributable to equity holders.
Adjusted Earnings per share - alternate performance
measure
The following calculation of the
basic and diluted earnings per share excluding exceptional items
has been calculated based on adding back the following deductions
from (loss) / profit after tax:
|
Year ended
31-Mar
|
Year ended
31-Mar
|
|
2024
|
2023
|
|
£000
|
£000
|
(Loss) / Profit for the period from
operations attributable to the equity shareholders of the parent
Company
|
(3,527)
|
514
|
Exceptional items -
Impairment
|
4,449
|
-
|
Exceptional items - Deferred tax
charge in relation to the Impairment
|
165
|
-
|
Exceptional items - Acquisition costs
(disallowed for tax provision)
|
-
|
312
|
Adjusted Earnings excluding
exceptional items
|
1,087
|
826
|
Adjusted Basic earnings per share -
excluding exceptional items
|
1.59p
|
1.19p
|
Adjusted Diluted earnings per share -
excluding exceptional items
|
1.42p
|
1.05p
|
6. Share capital
|
Ordinary shares of 1p
each
|
|
£000
|
Number
|
|
|
|
At 1 April 2022
|
697
|
69,756,183
|
Issued in the year
|
3
|
273,400
|
At 31 March 2023
|
700
|
70,029,583
|
Issued in the year
|
0
|
5,800
|
At 31 March 2024
|
700
|
70,035,383
|
The Company has one class of
ordinary shares which carry no right to fixed income. All of the
shares are issued and fully paid. The total proceeds from the issue
of shares from the exercise of share options in the year was £2,000
(2023: £74,000).
During the prior year, the Company
agreed a buy back of 1,600,000 Consideration Shares for an
aggregate consideration of £576,000. The consideration was based on
the price of 36p per ordinary share being the on-market price at
the time of the transaction. All purchases are for the purpose of
the finalisation of the Emma Hardie acquisition.
7. Notes to cash flow statement
Analysis of changes
in net debt
|
Overdraft
|
Invoice
Financing
|
Mortgage
|
Loan
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
At 1 April 2023
|
26
|
1,557
|
2,467
|
1,940
|
5,990
|
Cash outflow - principal
|
(61)
|
(1,557)
|
(180)
|
(1,329)
|
(3,127)
|
Cash outflow - interest
|
-
|
-
|
(72)
|
(123)
|
(195)
|
Interest accruing
|
72
|
-
|
72
|
123
|
267
|
|
|
|
|
|
|
At 31 March 2024
|
37
|
-
|
2,287
|
611
|
2,935
|
|
Overdraft
|
Invoice
Financing
|
Mortgage
|
Loan
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
At 1 April 2022
|
495
|
1,267
|
2,642
|
2,645
|
7,049
|
Cash flows
|
(600)
|
290
|
(252)
|
(816)
|
(1,378)
|
Interest accruing
|
131
|
-
|
77
|
111
|
319
|
|
|
|
|
|
|
At 31 March 2023
|
26
|
1,557
|
2,467
|
1,940
|
5,990
|
8. Status of information
In accordance with section 435 of
the Companies Act 2006, the directors advise that the financial
information set out in this announcement does not constitute the
Group's statutory financial statements for the year ended 31 March
2024 or 2023, but is derived from these financial statements. The
financial statements for the year ended 31 March 2023 have been
delivered to the Registrar of Companies. The financial statements
for the year ended 31 March 2024 have been
prepared in accordance with international financial reporting
standards adopted pursuant to Regulation (EC) No 1606/2002 as it
applies in the European Union. The financial statements for the
year ended 31 March 2024 will be forwarded to the Registrar of
Companies following the Company's Annual General Meeting. The
Auditors have reported on these financial statements; their reports
were unqualified and did not contain statements under Section
498(2) or (3) of the Companies Act 2006.
The consolidated statement of
financial position at 31 March 2024 and the consolidated statement
of comprehensive income, consolidated
statement of changes in equity and consolidated
statement of cash flows for the year then ended have been extracted
from the Group's financial statements. Those financial
statements have not yet been delivered to the
Registrar.
The strategic report with
supplementary material is expected to be posted to Shareholders
shortly. The annual report and accounts will also be available on
the Company's website at: www.creightonsplc.com and in hard copy to shareholders
upon request from the Company's registered
office at 1210 Lincoln Road, Peterborough, PE4
6ND.
The annual report and accounts for the period ended 31 March 2024
will be uploaded to the National Storage Mechanism and will be
available for viewing shortly at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The Directors will notify
shareholders when the accounts are posted and have been uploaded to
the website and to the NSM.
The Company's AGM will take place
at the offices of Potter & Moore
Innovations Ltd, 1210 Lincoln Road, Peterborough, PE4 6ND on
28 August 2024 at 12:00 noon.